Reference SummaryWilliams JL, Biochem Biophys Res Commun 2004 Jan 16;313(3):784-8
Title |
NO-donating aspirin inhibits intestinal carcinogenesis in Min (APC(Min/+)) mice. | ||||||
Authors |
Williams JL; Kashfi K; Ouyang N; del Soldato P; Kopelovich L; Rigas B | ||||||
Journal |
Biochem Biophys Res Commun | ||||||
Volume |
313 | ||||||
Issue |
3 | ||||||
Year |
2004 | ||||||
Pages |
784-8 | ||||||
Abstract |
The chemopreventive effect of nitric oxide-releasing aspirin (NO-ASA) against gastrointestinal tumorigenesis was evaluated in Min (APC(Min/+)) mice. NO-ASA consists of a traditional ASA that bears covalently attached to it an NO-releasing moiety. Four groups (N=10) of six-week-old female C57BL/6J APC(Min/+) and the corresponding C57BL/6J(+/+) wild type mice were treated either with vehicle or NO-ASA 100 mg/kg/day intrarectally for 21 days. There were no signs of overt toxicity including gastrointestinal toxicity from NO-ASA. Vehicle treated Min mice had 24.7 +/- 3.8 tumors (mean +/- SEM) and NO-ASA treated Min mice had 10.1 +/- 1.4 tumors (59% reduction; P<0.001). Wild type mice showed no tumors. NO-ASA did not affect cell proliferation in small intestinal mucosa, determined by immunohistochemical staining for PCNA. Our findings establish the strong inhibitory effect of NO-ASA in intestinal carcinogenesis in the Min mouse and suggest that this agent merits further evaluation as a chemopreventive agent against colon cancer. | ||||||
Links |
J:87459 – MGI References 14697260 – National Library of Medicine/PubMed |
||||||
Strain Notes
|
Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
---|---|---|---|---|---|
C57BL/6J-ApcMin/+ | Intestine - Small Intestine tumor | Intestine - Small Intestine |
observed |
||
C57BL/6J-ApcMin/+ | Intestine - Small Intestine tumor |
|
Intestine - Small Intestine |
90 |
|
C57BL/6J | Intestine - Small Intestine tumor | Intestine - Small Intestine |
0 |
||
C57BL/6J | Intestine - Small Intestine tumor |
|
Intestine - Small Intestine |
0 |